Company profile for Day One Biopharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Day One Biopharmaceuticals understands that advances in cancer research now enable drug developers to identify children and adults who may benefit from the same medicine. We are a unique company created to find and develop new therapies that meet the critical needs of people of all ages living with cancer – starting from the biology of childhood cancer. Our distinctive approach, together with our trusted network of pediatric...
Day One Biopharmaceuticals understands that advances in cancer research now enable drug developers to identify children and adults who may benefit from the same medicine. We are a unique company created to find and develop new therapies that meet the critical needs of people of all ages living with cancer – starting from the biology of childhood cancer. Our distinctive approach, together with our trusted network of pediatric oncology investigators, gives us an unparalleled ability to advance promising discoveries for patients of any age.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
2765 Sand Hill Rd, Menlo Park, California, 94025
Telephone
Telephone
1-650-484-0899
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/24/3193443/0/en/Day-One-Announces-Three-Year-Follow-Up-Data-From-OJEMDA-tovorafenib-Phase-2-FIREFLY-1-Trial-at-the-2025-Society-for-Neuro-Oncology-SNO-Annual-Meeting.html

GLOBENEWSWIRE
24 Nov 2025

https://www.globenewswire.com/news-release/2025/11/18/3190013/0/en/Day-One-to-Participate-in-the-Piper-Sandler-37th-Annual-Healthcare-Conference.html

GLOBENEWSWIRE
18 Nov 2025

https://www.globenewswire.com/news-release/2025/11/13/3187105/0/en/Day-One-Biopharmaceuticals-to-Acquire-Mersana-Therapeutics.html

GLOBENEWSWIRE
13 Nov 2025

https://www.globenewswire.com/news-release/2025/11/10/3184366/0/en/Day-One-Announces-New-OJEMDA-tovorafenib-Data-to-be-Presented-in-Oral-Session-at-the-2025-Society-for-Neuro-Oncology-SNO-Annual-Meeting.html

GLOBENEWSWIRE
10 Nov 2025

https://www.globenewswire.com/news-release/2025/11/04/3180800/0/en/Day-One-Reports-Third-Quarter-2025-Financial-Results-and-Corporate-Progress.html

GLOBENEWSWIRE
04 Nov 2025

https://www.globenewswire.com/news-release/2025/10/21/3170198/0/en/Day-One-to-Report-Third-Quarter-2025-Financial-Results-Tuesday-November-4-2025.html

GLOBENEWSWIRE
21 Oct 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty